Dr. Chapman said plasma administration needs to be studied in a broader range of settings where emergency treatment is not so homogeneous.
It’s a challenging proposition but “the logistics might get easier when freeze-dried plasma becomes approved for use,” he said.
The studies used thawed plasma, which has a shelf life of just five days once thawed. Never-frozen plasma is good for 30 days. Freeze-dried plasma, with a virtually unlimited shelf life, is not available in the U.S. but has been approved for use in France.
It would also be helpful if researchers could come up with a better system to identify which patients are in hemorrhagic shock, he said. Dr. Chapman and his colleagues are actively working on that challenge.
Pages: 1 2 3 | Single Page
No Responses to “Time-to-Hospital May Be Key to Disparate Results in Studies on Pre-Hospital Plasma Administration”